596 related articles for article (PubMed ID: 28797868)
1. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
2. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study.
Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC
Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4-6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo.
Myftiu B; Hundozi Z; Sermaxhaj F; Blyta A; Shala N; Jashari F; Qorraj Bytyqi H; Hyseni E; Kurtishi I
Med Sci Monit; 2022 Aug; 28():e937856. PubMed ID: 36042691
[TBL] [Abstract][Full Text] [Related]
7. The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.
Lavoie Smith EM; Cohen JA; Pett MA; Beck SL
Oncol Nurs Forum; 2011 Mar; 38(2):133-42. PubMed ID: 21356652
[TBL] [Abstract][Full Text] [Related]
8. Reflexology in the management of chemotherapy induced peripheral neuropathy: A pilot randomized controlled trial.
Kurt S; Can G
Eur J Oncol Nurs; 2018 Feb; 32():12-19. PubMed ID: 29353627
[TBL] [Abstract][Full Text] [Related]
9. Assessment of chemotherapy-induced peripheral neuropathy using the LDIFLARE technique: a novel technique to detect neural small fiber dysfunction.
Sharma S; Venkitaraman R; Vas PR; Rayman G
Brain Behav; 2015 Jul; 5(7):e00354. PubMed ID: 26221574
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
Bennedsgaard K; Ventzel L; Andersen NT; Themistocleous AC; Bennett DL; Jensen TS; Tankisi H; Finnerup NB
J Peripher Nerv Syst; 2020 Dec; 25(4):377-387. PubMed ID: 32902058
[TBL] [Abstract][Full Text] [Related]
11. A Randomized Controlled Trial to Assess the Effectiveness of Muscle Strengthening and Balancing Exercises on Chemotherapy-Induced Peripheral Neuropathic Pain and Quality of Life Among Cancer Patients.
Dhawan S; Andrews R; Kumar L; Wadhwa S; Shukla G
Cancer Nurs; 2020; 43(4):269-280. PubMed ID: 30888982
[TBL] [Abstract][Full Text] [Related]
12. Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain.
Bechakra M; Nieuwenhoff MD; van Rosmalen J; Groeneveld GJ; Scheltens-de Boer M; Sonneveld P; van Doorn PA; de Zeeuw CI; Jongen JL
Mol Pain; 2018; 14():1744806918797042. PubMed ID: 30152246
[TBL] [Abstract][Full Text] [Related]
13. A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis.
Fontes F; Pereira S; Castro-Lopes JM; Lunet N
Breast; 2016 Oct; 29():31-8. PubMed ID: 27394676
[TBL] [Abstract][Full Text] [Related]
14. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
15. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy.
Andersen Hammond E; Pitz M; Steinfeld K; Lambert P; Shay B
Neurorehabil Neural Repair; 2020 Mar; 34(3):235-246. PubMed ID: 31976819
[No Abstract] [Full Text] [Related]
16. Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain.
Blanton HL; Brelsfoard J; DeTurk N; Pruitt K; Narasimhan M; Morgan DJ; Guindon J
Drugs; 2019 Jun; 79(9):969-995. PubMed ID: 31127530
[TBL] [Abstract][Full Text] [Related]
17. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
Andersen Hammond E; Pitz M; Shay B
Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
[TBL] [Abstract][Full Text] [Related]
19. Depletion of nerve growth factor in chemotherapy-induced peripheral neuropathy associated with hematologic malignancies.
Youk J; Kim YS; Lim JA; Shin DY; Koh Y; Lee ST; Kim I
PLoS One; 2017; 12(8):e0183491. PubMed ID: 28827818
[TBL] [Abstract][Full Text] [Related]
20. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies.
Krøigård T; Schrøder HD; Qvortrup C; Eckhoff L; Pfeiffer P; Gaist D; Sindrup SH
Eur J Neurol; 2014 Apr; 21(4):623-9. PubMed ID: 24460946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
